Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-VEGF”

493 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 493 results

Not applicableStudy completedNCT02474225
What this trial is testing

Intraocular Pressure Change Following Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agent

Who this might be right for
Intraocular Pressure
Prince of Songkla University 70
Not applicableStudy completedNCT01914380
What this trial is testing

Investigating the Effectiveness of Eylea in Patients With Wet Age-related Macular Degeneration

Who this might be right for
Wet Age-related Macular Degeneration
Bayer 988
Post-approval studies (Phase 4)Study completedNCT01710839
What this trial is testing

Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion

Who this might be right for
Central Retinal, Hemi Retinal & Brach Retinal Vein Occlusions
Charles C Wykoff, PhD, MD 30
Not applicableStudy completedNCT00897754
What this trial is testing

Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab

Who this might be right for
Colorectal Cancer
ECOG-ACRIN Cancer Research Group 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04101877
What this trial is testing

The Sahlgrenska Anti-VEGF Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Vastra Gotaland Region 402
Not applicableUnknownNCT03577041
What this trial is testing

Medico-economic Evaluation of Anti-VEGF Treatments in the Treatment of naïve Age-related Macular Degeneration (AMD): a Model Adapted to the French Context

Who this might be right for
Age-related Macular Degeneration (AMD)
Centre Hospitalier Universitaire, Amiens 600
Early research (Phase 1)WithdrawnNCT03644459
What this trial is testing

Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101

Who this might be right for
Ovarian CancerCervical CancerColorectal Cancer+1 more
Lynkcell Inc.
Early research (Phase 1)Looking for participantsNCT05802329
What this trial is testing

Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)

Who this might be right for
Center Involved Diabetic Macular EdemaDiabetic Macular Edema
Ocugen 24
Post-approval studies (Phase 4)UnknownNCT04380974
What this trial is testing

Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Xiaodong Sun 102
Post-approval studies (Phase 4)Study completedNCT01027481
What this trial is testing

Ranibizumab in Patients With Branch Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Medical University of Vienna 30
Post-approval studies (Phase 4)Active Not RecruitingNCT05610319
What this trial is testing

Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial

Who this might be right for
Diabetic Macular Edema
McMaster University 446
Early research (Phase 1)Study completedNCT01057264
What this trial is testing

HAI Abraxane With Gemcitabine and Bevacizumab

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 78
Early research (Phase 1)Study completedNCT00749021
What this trial is testing

Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments

Who this might be right for
Retinal Pigment Epithelial Detachment
Clement K. Chan 40
Early research (Phase 1)Study completedNCT00530907
What this trial is testing

Valproic Acid and Bevacizumab in Patients With Advanced Cancer

Who this might be right for
Advanced Cancer
M.D. Anderson Cancer Center 71
Testing effectiveness (Phase 2)Ended earlyNCT02348359
What this trial is testing

X-82 to Treat Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration (AMD)Macular DegenerationExudative Age-related Macular Degeneration+5 more
Tyrogenex 157
Not applicableLooking for participantsNCT07642960
What this trial is testing

Fine-needle Diathermy Combined With Subconjunctival Bevacizumab for Corneal Neovascularization

Who this might be right for
Corneal Neovascularisation
HoChiMinh City Eye Hospital 51
Not applicableStudy completedNCT06881433
What this trial is testing

Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without HAIC for Unresectable HCC With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhongda Hospital 1,649
Not applicableStudy completedNCT04523844
What this trial is testing

Brinzolamide-brimonidine Fixed Combination for Preventing IOP Elevation After Intravitreal Anti-VEGF Injections

Who this might be right for
Eye DiseasesInjection ComplicationIntraocular Pressure
General Hospital of Athens Elpis 47
Early research (Phase 1)Ended earlyNCT00426829
What this trial is testing

Proton Therapy and Bevacizumab for Primary Liver Tumors

Who this might be right for
Liver CancerHepatocellular CarcinomaCholangiocarcinoma
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07064902
What this trial is testing

Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 48
Load More Results